Larry E Kahn

Title: Larry E Kahn: Innovator in Hematopoietic Research

Introduction

Larry E Kahn is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of hematopoietic research, holding 2 patents that reflect his innovative work. His inventions focus on advancing medical science, particularly in the areas of thrombopoietin and monoclonal antibodies.

Latest Patents

One of Larry E Kahn's latest patents is titled "Thrombopoietin: IL-3 fusion protein." This invention relates to variants of human c-mpl ligands (thrombopoietin) that have activity on hematopoietic differentiation and expansion. Another significant patent is for "Monoclonal antibodies against IgE-associated determinants, hybrid cell." This invention is directed towards monoclonal antibodies and hybridomas that produce them, which react with IgE when it is unbound, thereby inhibiting IgE binding to mast cells. It also reacts with IgE when it is bound to the B-cell FcE receptor, but does not react with IgE when it is bound to the mast cell FcE receptor.

Career Highlights

Larry E Kahn has worked at G.D. Searle & Company, where he has been able to apply his expertise in developing innovative solutions in the medical field. His work has contributed to advancements in understanding and treating various health conditions.

Collaborations

Throughout his career, Larry has collaborated with notable colleagues such as Bonita J Rup and Nicholas R Staten. These collaborations have further enhanced his research and development efforts.

Conclusion

Larry E Kahn is a distinguished inventor whose work in hematopoietic research has led to valuable patents that contribute to medical advancements. His innovative spirit and collaborative efforts continue to make a significant impact in the field.